Kaliumklorid Eql Pharma

Potassium chloride, the active ingredient in Kaliumklorid Eql Pharma, is an electrolyte supplement presented as an oral formulation for oral use. It is employed to correct low serum potassium levels and manage potassium deficiency in patients requiring repletion.

GNH USA supplies Kaliumklorid Eql Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU regulatory standards and is distributed through GNH USA's global network. Its quality is ensured by rigorous manufacturing controls and batch testing.

Kaliumklorid Eql Pharma provides potassium chloride to address electrolyte disturbances associated with low potassium levels. - Hypokalemia: restores normal serum potassium concentrations in patients with clinically significant potassium depletion. - Potassium deficiency due to diuretic therapy: replenishes potassium lost during prolonged diuretic use. - Prevention of arrhythmias in patients at risk of low potassium: helps maintain cardiac electrical stability by correcting potassium deficits.

Potassium chloride may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild stomach upset after oral intake. - Abdominal discomfort: cramping or pain in the abdomen. - Diarrhea: loose stools occurring shortly after dosing. - Taste disturbance: metallic or salty taste in the mouth. - Flatulence: increased gas production. - Vomiting: occasional emesis.

Serious or Rare Side Effects: - Hyperkalemia: dangerously high serum potassium that can affect heart rhythm. - Cardiac arrhythmia: irregular heartbeat potentially leading to syncope. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Muscle weakness: notable loss of strength or paralysis. - Respiratory depression: impaired breathing in extreme cases.

When prescribing potassium chloride, clinicians should observe several safety measures to minimize risk. - Monitor serum potassium: check levels before initiation and regularly during therapy. - Adjust dose in renal impairment: reduce dosage or increase monitoring in patients with reduced kidney function. - Avoid in hyperkalemia: do not administer to individuals with already elevated potassium levels. - Review concomitant medications: assess for drugs that increase potassium to prevent accumulation. - Caution with ACE inhibitors or ARBs: these agents can potentiate potassium rise. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Potassium chloride can interact with several medicines, altering potassium balance or cardiac function.

Major Interactions (Avoid): - ACE inhibitors or ARBs: combined use may cause severe hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): risk of excessive potassium accumulation. - NSAIDs: can reduce renal potassium excretion, increasing serum levels. - Trimethoprim: may impair potassium clearance, leading to hyperkalemia. - Heparin therapy: can decrease aldosterone production, raising potassium.

Moderate Interactions (Monitor Closely): - Digoxin: elevated potassium can modify digoxin toxicity risk. - Beta‑blockers: may mask symptoms of hyperkalemia. - Lithium: potassium shifts can affect lithium levels. - Certain antibiotics (e.g., penicillamine): may influence potassium handling. - Insulin therapy: rapid shifts in potassium may occur, requiring monitoring.